Veradermics, Incorporated
MANE
$126.89
$7.526.30%
NYSE
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 390.80M | 141.86M | 53.08M | ||
| Total Receivables | 1.65M | 1.26M | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 4.02M | 5.61M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 602.00K | 3.77M | -- | ||
| Total Current Assets | 397.07M | 152.49M | -- | ||
|
|
|||||
| Total Current Assets | 397.07M | 152.49M | -- | ||
| Net Property, Plant & Equipment | 287.00K | 125.00K | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | 397.36M | 152.62M | -- | ||
|
|
|||||
| Total Accounts Payable | 1.07M | 2.13M | -- | ||
| Total Accrued Expenses | 5.61M | 6.98M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | 39.00K | 47.00K | -- | ||
| Total Other Current Liabilities | 39.00K | 47.00K | -- | ||
| Total Current Liabilities | 6.72M | 9.15M | -- | ||
|
|
|||||
| Total Current Liabilities | 6.72M | 9.15M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | 4.00K | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 6.72M | 9.16M | -- | ||
|
|
|||||
| Common Stock & APIC | 543.05M | 2.35M | -- | ||
| Retained Earnings | -150.65M | -123.42M | -- | ||
| Treasury Stock & Other | -1.75M | -1.79M | -- | ||
| Total Common Equity | 390.64M | -122.86M | -52.33M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 266.33M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 266.33M | 103.15M | ||
|
|
|||||
| Total Common Equity | 390.64M | -122.86M | -52.33M | ||
| Total Preferred Equity | -- | 266.33M | 103.15M | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 390.64M | 143.46M | 50.82M | ||
|
|
|||||